⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1270359 | 0.78 | TSHR (0.41) | — | |
| SCHEMBL15491807 | 0.72 | — | — | |
| SCHEMBL13933329 | 0.72 | — | — | |
| SCHEMBL24134597 | 0.72 | KCNH2 (0.35) | — | |
| SCHEMBL26973008 | 0.71 | — | — | |
| SCHEMBL13861306 | 0.71 | — | — | |
| SCHEMBL5909124 | 0.71 | CHRNB2 (0.30) | — | |
| SCHEMBL17113863 | 0.70 | TP53 (0.31) | — | |
| SCHEMBL25090761 | 0.69 | — | — | |
| Bromide SCHEMBL6847337 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174014-B2 | Compounds, compositions, and methods for increasing CFTR activity | PROTEOSTASIS THERAPEUTICS, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-20170233379-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY | PROTEOSTASIS THERAPEUTICS, INC. | 2017-08-17 | — | — | US | disclosed |